Vivos Inc to Present at The LD 500 Virtual Conference

Author's Avatar
Sep 01, 2020
Article's Main Image

LOS ANGELES, CA / ACCESSWIRE / September 1, 2020 / Vivos Inc (OTCQB:RDGL), a company that has developedan Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals and in humans, today announced that it will be presenting at the LD 500 investor conference on Thursday September 3 at 1:40 PST / 4:00 PM EST. Dr. Mike Korenko (CEO of Vivos Inc) will be presenting to a live virtual audience.